Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot and VR join forces to spot hidden stroke deficits

NCT ID NCT07290218

Knowledge-focused Sponsor: Fondazione Don Carlo Gnocchi Onlus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new robotic and virtual reality system called NeglectARm 3D in 15 people who have spatial neglect after a stroke. The system uses a robot arm and VR headset to measure how well patients notice objects in 3D space. Researchers want to see if the device is easy to use, safe, and gives reliable results compared to standard paper tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Non-CE-marked robotic device (NeglectARm 3D) with virtual reality headset
What this could lead to
If successful, this could lead to a more precise, objective tool for diagnosing spatial neglect after stroke, improving rehabilitation planning.
What could go wrong
This is a very small early-stage study (15 participants) focused on feasibility, not treatment. The device is not yet approved, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The enrollment phase will be conducted at the IRCCS Fondazione Don Carlo Gnocchi in Florence (FI) and at the Fondazione Don Carlo Gnocchi in Sant'Angelo dei Lombardi (AV), in Italy. Each patient will be considered enrolled after assessment of inclusion and exclusion criteria and after signing the informed consent form. A total of 15 patients will be recruited, with 10 participants at the Florence center and 5 participants at the Sant'Angelo dei Lombardi center.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 years; * Diagnosis of ischemic or hemorrhagic stroke; * Diagnosis of Unilateral Spatial Neglect (assessed by The Hearts Test, Oxford Cognitive Screen, cut-off ± 2); * Signed informed consent form. Exclusion Criteria: * Presence of language deficits (inability to complete the OCS test); * Presence of cognitive decline prior to the stroke event; * Presence of severe visual and/or hearing impairments; * Language barriers; * Orthopedic, neurological, or psychiatric conditions that could interfere with the study or with the assessment of motor and cognitive function; * Uncontrolled epilepsy despite antiepileptic treatment; * Behavioral disorders that may interfere with study participation; * Presence of medical devices whose functioning could be compromised (e.g., pacemaker, etc.); * Object-centered neglect (assessed by the OCS Hearts Test; object asymmetry ± 2).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain injured patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain injury hemorrhagic stroke ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain injured patients Neglect Post-stroke cognitive impairment Stroke Unilateral spatial neglect (USN)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo

    Sant'Angelo dei Lombardi, AV, 83054, Italy

  • IRCSS Fondazione Don Carlo Gnocchi

    Florence, FI, 50143, Italy

  • Scuola Superiore Sant'Anna

    Pisa, PI, 56127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.